The PurpleLab^® Resource Center

This case study explores how a pharmaceutical company successfully planned and executed a Phase III clinical trial for a new oncology drug.

Authored by Lauren Kushner, Head of Healthcare at MiQ, and Ted Sweetser, VP of Advertising Partnerships and Strategy at PurpleLab. 2024 was a year of considerable change for the pharmaceutical industry. The biggest trend was undoubtedly the progression of the Inflation Reduction Act’s negotiated drug pricing, which sees CMS negotiating on pricing for a published…

Healthcare advertisers and their marketing partners face challenges that other direct to consumer advertisers may not necessarily be confronted with. Namely, the ever-evolving world of privacy regulation and the requirements enacted by the federal and state governments with the goal of helping preserve patient anonymity.